Cargando…
CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant, recurrent and drug-resistant tumor, and patients often lose the opportunity for surgery when they are diagnosed. Abnormal gene expression is closely related to the occurrence of HCC. The aim of the present study was to identify the di...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710976/ https://www.ncbi.nlm.nih.gov/pubmed/34992437 http://dx.doi.org/10.2147/IJGM.S341379 |
_version_ | 1784623281790255104 |
---|---|
author | Yang, Zhiqiang Wu, Xinglang Li, Junbo Zheng, Qiang Niu, Junwei Li, Shengwei |
author_facet | Yang, Zhiqiang Wu, Xinglang Li, Junbo Zheng, Qiang Niu, Junwei Li, Shengwei |
author_sort | Yang, Zhiqiang |
collection | PubMed |
description | BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant, recurrent and drug-resistant tumor, and patients often lose the opportunity for surgery when they are diagnosed. Abnormal gene expression is closely related to the occurrence of HCC. The aim of the present study was to identify the differentially expressed genes (DEGs) between tumor tissue and non-tumor tissue of HCC samples in order to investigate the mechanisms of liver cancer. METHODS: The gene expression profile (GSE62232, GSE89377, and GSE112790) was downloaded from the Gene Expression Omnibus (GEO) and analyzed using the online tool GEO2R to identify differentially expressed genes (DEGs). Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integrated Discovery. Protein–protein interaction (PPI) of these DEGs was analyzed based on the Search Tool for the Retrieval of Interacting Genes database and visualized by Cytoscape software. In addition, we used the online Kaplan–Meier plotter survival analysis tool to evaluate the prognostic value of hub genes expression. HPA database was used to reveal the differences in protein level of hub genes. RESULTS: A total of 50 upregulated DEGs and 122 downregulated DEGs were identified. Among them, ten hub genes with a high degree of connectivity were picked out. Overexpression of these hub genes was associated with unfavorable prognosis of HCC. CONCLUSION: Our study suggests that CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM were overexpressed in HCC compared with normal liver tissue. Overexpression of these genes was an unfavorable prognostic factor of HCC patients. Further study is needed to explore the value of them in the diagnosis and treatment of HCC. |
format | Online Article Text |
id | pubmed-8710976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87109762022-01-05 CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis Yang, Zhiqiang Wu, Xinglang Li, Junbo Zheng, Qiang Niu, Junwei Li, Shengwei Int J Gen Med Original Research BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant, recurrent and drug-resistant tumor, and patients often lose the opportunity for surgery when they are diagnosed. Abnormal gene expression is closely related to the occurrence of HCC. The aim of the present study was to identify the differentially expressed genes (DEGs) between tumor tissue and non-tumor tissue of HCC samples in order to investigate the mechanisms of liver cancer. METHODS: The gene expression profile (GSE62232, GSE89377, and GSE112790) was downloaded from the Gene Expression Omnibus (GEO) and analyzed using the online tool GEO2R to identify differentially expressed genes (DEGs). Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integrated Discovery. Protein–protein interaction (PPI) of these DEGs was analyzed based on the Search Tool for the Retrieval of Interacting Genes database and visualized by Cytoscape software. In addition, we used the online Kaplan–Meier plotter survival analysis tool to evaluate the prognostic value of hub genes expression. HPA database was used to reveal the differences in protein level of hub genes. RESULTS: A total of 50 upregulated DEGs and 122 downregulated DEGs were identified. Among them, ten hub genes with a high degree of connectivity were picked out. Overexpression of these hub genes was associated with unfavorable prognosis of HCC. CONCLUSION: Our study suggests that CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM were overexpressed in HCC compared with normal liver tissue. Overexpression of these genes was an unfavorable prognostic factor of HCC patients. Further study is needed to explore the value of them in the diagnosis and treatment of HCC. Dove 2021-12-22 /pmc/articles/PMC8710976/ /pubmed/34992437 http://dx.doi.org/10.2147/IJGM.S341379 Text en © 2021 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Yang, Zhiqiang Wu, Xinglang Li, Junbo Zheng, Qiang Niu, Junwei Li, Shengwei CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis |
title | CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis |
title_full | CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis |
title_fullStr | CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis |
title_full_unstemmed | CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis |
title_short | CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis |
title_sort | ccnb2, cdc20, aurka, top2a, melk, ncapg, kif20a, ube2c, prc1, and aspm may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710976/ https://www.ncbi.nlm.nih.gov/pubmed/34992437 http://dx.doi.org/10.2147/IJGM.S341379 |
work_keys_str_mv | AT yangzhiqiang ccnb2cdc20aurkatop2amelkncapgkif20aube2cprc1andaspmmaybepotentialtherapeutictargetsforhepatocellularcarcinomausingintegratedbioinformaticanalysis AT wuxinglang ccnb2cdc20aurkatop2amelkncapgkif20aube2cprc1andaspmmaybepotentialtherapeutictargetsforhepatocellularcarcinomausingintegratedbioinformaticanalysis AT lijunbo ccnb2cdc20aurkatop2amelkncapgkif20aube2cprc1andaspmmaybepotentialtherapeutictargetsforhepatocellularcarcinomausingintegratedbioinformaticanalysis AT zhengqiang ccnb2cdc20aurkatop2amelkncapgkif20aube2cprc1andaspmmaybepotentialtherapeutictargetsforhepatocellularcarcinomausingintegratedbioinformaticanalysis AT niujunwei ccnb2cdc20aurkatop2amelkncapgkif20aube2cprc1andaspmmaybepotentialtherapeutictargetsforhepatocellularcarcinomausingintegratedbioinformaticanalysis AT lishengwei ccnb2cdc20aurkatop2amelkncapgkif20aube2cprc1andaspmmaybepotentialtherapeutictargetsforhepatocellularcarcinomausingintegratedbioinformaticanalysis |